JP2019514872A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514872A5
JP2019514872A5 JP2018554716A JP2018554716A JP2019514872A5 JP 2019514872 A5 JP2019514872 A5 JP 2019514872A5 JP 2018554716 A JP2018554716 A JP 2018554716A JP 2018554716 A JP2018554716 A JP 2018554716A JP 2019514872 A5 JP2019514872 A5 JP 2019514872A5
Authority
JP
Japan
Prior art keywords
compound
nash
use according
formula
nafld
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018554716A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514872A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/028529 external-priority patent/WO2017184819A1/en
Publication of JP2019514872A publication Critical patent/JP2019514872A/ja
Publication of JP2019514872A5 publication Critical patent/JP2019514872A5/ja
Pending legal-status Critical Current

Links

JP2018554716A 2016-04-22 2017-04-20 (非)アルコ−ル性脂肪肝炎又は非アルコ−ル性脂肪性肝疾患の治療のためのナルメフェン(NALMEFENE)、ナルトレキソン(naltrexone)及びその関連誘導体の応用 Pending JP2019514872A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662326435P 2016-04-22 2016-04-22
US62/326,435 2016-04-22
US201662395436P 2016-09-16 2016-09-16
US62/395,436 2016-09-16
PCT/US2017/028529 WO2017184819A1 (en) 2016-04-22 2017-04-20 Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis or non-alcoholic fatty liver disease

Publications (2)

Publication Number Publication Date
JP2019514872A JP2019514872A (ja) 2019-06-06
JP2019514872A5 true JP2019514872A5 (cg-RX-API-DMAC7.html) 2020-03-05

Family

ID=58668969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018554716A Pending JP2019514872A (ja) 2016-04-22 2017-04-20 (非)アルコ−ル性脂肪肝炎又は非アルコ−ル性脂肪性肝疾患の治療のためのナルメフェン(NALMEFENE)、ナルトレキソン(naltrexone)及びその関連誘導体の応用

Country Status (10)

Country Link
US (1) US10045977B2 (cg-RX-API-DMAC7.html)
EP (1) EP3445363A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019514872A (cg-RX-API-DMAC7.html)
KR (1) KR20180129909A (cg-RX-API-DMAC7.html)
CN (2) CN117137917A (cg-RX-API-DMAC7.html)
AU (1) AU2017253228B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018071705A2 (cg-RX-API-DMAC7.html)
CA (1) CA3021788C (cg-RX-API-DMAC7.html)
RU (1) RU2717677C1 (cg-RX-API-DMAC7.html)
WO (1) WO2017184819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
ES2860423T3 (es) 2014-05-28 2021-10-05 Childrens Hospital Med Ct Métodos y sistemas para convertir células precursoras en tejidos gástricos mediante diferenciación dirigida
WO2016061464A1 (en) 2014-10-17 2016-04-21 Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center In vivo model of human small intetine using pluripotent stem cells and methods of making and using same
JP6963882B2 (ja) 2016-05-05 2021-11-10 チルドレンズ ホスピタル メディカル センター 胃底部組織のインビトロでの製造のための方法及び当該方法と関連した組成物
CN109475626A (zh) * 2016-07-14 2019-03-15 儿童医院医疗中心 治疗纤维化的方法
EP3534907A4 (en) 2016-11-04 2020-06-24 Children's Hospital Medical Center COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASE
EP3548507A4 (en) 2016-12-05 2020-07-15 Children's Hospital Medical Center COLON ORGANOIDS AND PROCESSES FOR THE PREPARATION AND USE THEREOF
EP3609997A4 (en) 2017-04-14 2021-03-03 Children's Hospital Medical Center COMPOSITIONS OF STEM CELLS FROM MULTIPLE DONOR CELLS AND THEIR PREPARATION PROCEDURES
CA3077442A1 (en) 2017-10-10 2019-04-18 Children's Hospital Medical Center Esophageal tissue and/or organoid compositions and methods of making same
WO2019126626A1 (en) 2017-12-21 2019-06-27 Children's Hospital Medical Center Digitalized human organoids and methods of using same
SG11202100533VA (en) 2018-07-26 2021-02-25 Childrens Hospital Med Ct Hepato-biliary-pancreatic tissues and methods of making same
CA3112026A1 (en) 2018-09-12 2020-03-19 Children's Hospital Medical Center Organoid compositions for the production of hematopoietic stem cells and derivatives thereof
US12497597B2 (en) 2019-05-31 2025-12-16 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
KR20230073125A (ko) 2021-11-18 2023-05-25 (주)인벤티지랩 난용성 약물을 포함하는 마이크로 입자의 제조 방법
AU2022394933A1 (en) 2021-11-18 2024-05-09 Inventage Lab Inc. Sustained-release injectable composition containing naltrexone and method for preparing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
US7923454B2 (en) * 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
MXPA04011327A (es) 2002-05-17 2005-08-15 Jenken Biosciences Inc Opioides y compuestos similares a opioides y usos de los mismos.
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US10363251B2 (en) * 2009-07-16 2019-07-30 Mallinckrodt Llc (+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
TR201002473A2 (tr) * 2010-03-31 2011-09-21 Mustafa Nevzat �La� Sanay�� A.�. Herpes zoster hastalığının bır opiat reseptör antagonist kullanılarak tedavi yöntemi.
CN102048733B (zh) * 2010-12-23 2011-12-28 武汉同源药业有限公司 盐酸纳美芬在制备治疗脂肪肝的药物中的用途
JP6246895B2 (ja) * 2013-04-22 2017-12-13 カディラ・ヘルスケア・リミテッド 非アルコール性脂肪性肝疾患(nafld)のための新規組成物
EP3416619A2 (en) * 2016-02-18 2018-12-26 Immune Therapeutics, Inc. Method for inducing a sustained immune response

Similar Documents

Publication Publication Date Title
JP2019514872A5 (cg-RX-API-DMAC7.html)
AU2017253228B2 (en) Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis or non-alcoholic fatty liver disease
WO2021143912A1 (zh) 无细胞脂肪提取液对脂肪肝及其并发症的治疗作用
KR100877600B1 (ko) 메타독신 및 마늘유를 유효성분으로 함유하는 알코올성지방간 및 지방간성 간염의 예방 및 치료용 약학 조성물
WO2016195355A1 (ko) 필버톤의 신규한 용도
JP6157928B2 (ja) 肝臓への脂肪蓄積抑制剤
KR20150130352A (ko) 지방간 질환을 치료하는 방법
WO2012026928A1 (en) Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
KR102013574B1 (ko) 하이드로퀴논 유도체를 포함하는 비만 또는 비알콜성 지방간염의 예방 또는 치료용 약학 조성물
JP6914256B2 (ja) 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法
WO2006034624A1 (fr) Procede pour la preparation d’une preparation de tetrodotoxine a base d’huile
US20180318290A1 (en) Use of nalmefene in non-alcoholic steatohepatitis
TW201813646A (zh) 納美芬(nalmefene)在非酒精性脂肪肝炎(nash)的應用
CN113181178A (zh) 盐酸去亚甲基四氢小檗碱在制备预防或治疗疼痛药物中的应用
CN113813281A (zh) 肌苷在制备预防和治疗结核病药物中的应用
WO2019242764A1 (zh) 糖苷类化合物在制备防治糖尿病并发症的药物中的应用
US20190142764A1 (en) Methods for treatment of interstitial cystitis
JP7720104B2 (ja) トルセミドおよびクロモリンを含む代謝疾患予防または治療用組成物
KR20190130241A (ko) 크로몰린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 지방간의 예방 또는 치료용 약학적 조성물
EP4321161A1 (en) Compound for prevention or treatment of kidney disease
JP6437183B2 (ja) 肝機能改善剤
CN113368107B (zh) 包含小檗碱和苦参碱的药物组合物及其治疗或预防非酒精性脂肪性肝病的用途
CN1647800A (zh) 一种河鲀油制剂及其制备方法
WO2016152965A1 (ja) 低アルブミン血症の改善剤
CN115778957A (zh) 千金藤素及包含其的组合物用于预防或治疗酒精性肝病的应用